LSE Principal Investigator: Huseyin Naci
Start Date: May 2023
End Date: December 2023
Regions: UK
Countries: UK
Keywords: pharmaceutical policy, prescription drugs

The National Institute for Health and Care Excellence (NICE) in England is tasked with recommending to the NHS whether new drugs should be reimbursed. NICE relies on cost-effectiveness analyses to determine whether new drugs offer good value for money for the NHS. However, the impact of NICE recommendations on the NHS has not been empirically evaluated. This project evaluates the efficiency of pharmaceutical spending in England. 

Topic classification: Health policy, health technology regulation & assessment